comparemela.com

Latest Breaking News On - Stephan jackman - Page 1 : comparemela.com

Alzamend Neuro Receives FDA Study May Proceed Notification for a Phase IIA Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, in Post-Traumatic Stress Disorder Patients | Region

ATLANTA (BUSINESS WIRE) Dec 11, 2023

United statesStephan jackmanSecurities exchangeAlzamend neuro incExchange commissionAmerican psychiatric associationDrug administrationUniversity of south florida research foundation incChief executive officerStudy may proceedNew drug applicationMayo clinicSouth florida research foundationSecurities actSecurities exchange actAlzamend neuro

Alzamend Neuro Plans To Kickstart Stress Disorder Study With Next-Gen Lithium Product Next Year

Alzamend Neuro Inc ALZN received a "Study May Proceed" letter from the FDA for the initiation of study AL001-PTSD01, a Phase 2A study of AL001 for…

Stephan jackmanAlzamend neuro incChief executive officerReaking news

EXCLUSIVE: Alzamend Neuro Plans To Kickstart Stress Disorder Study With Next-Gen Lithium Product Next Year - Alzamend Neuro (NASDAQ:ALZN)

Alzamend Neuro Inc (NASDAQ: ALZN) received a "Study May Proceed" letter from the FDA for the initiation of study AL001-PTSD01, a Phase 2A study of AL001 for 

United statesStephan jackmanChief executive officerAlzamend neuro

EXCLUSIVE: Alzamend Neuro Receives FDA Go-Ahead Letter For Mid-Stage Major Depressive Disorder Study - Alzamend Neuro (NASDAQ:ALZN)

Alzamend Neuro Inc (NASDAQ: ALZN) has received a "Study May Proceed" letter from the FDA for the initiation of study AL001-MDD01, a Phase 2A clinical study of AL001 for 

United statesStephan jackmanChief executive officerAlzamend neuro

Alzamend Neuro Gets FDA Approval for Trial of Depression Treatment

By Dean Seal Alzamend Neuro has gotten the go-ahead from federal regulators to launch a clinical study of its treatment for major depressive disorder. The biopharmaceutical company said.

Stephan jackmanDrug administrationDean sealExecutive stephan jackmanDow jones

vimarsana © 2020. All Rights Reserved.